Haemonetics Corp (HAE) — 8-K Filings

8-K Filings (17)

• 8-K Filing — May 7, 2026
• Haemonetics Corp Files 8-K on Shareholder Votes — Jul 25, 2025 Risk: low
  Haemonetics Corporation filed an 8-K on July 25, 2025, reporting on matters submitted to a vote of security holders as of July 24, 2025. The filing details even
• Haemonetics Corp. Reports Financials and Exit Costs — May 8, 2025 Risk: medium
  Haemonetics Corp. announced on May 6, 2025, that it is reporting results of operations and financial condition. The company also disclosed costs associated with
• Haemonetics CFO Departs; Interim Appointed — Mar 3, 2025 Risk: medium
  Haemonetics Corporation announced on March 3, 2025, the departure of its Chief Financial Officer, Brenda L. Foster, effective March 1, 2025. The company also an
• Haemonetics Corp Files 8-K — Jan 14, 2025 Risk: low
  Haemonetics Corporation filed an 8-K on January 14, 2025, to report other events and financial statements. The filing does not contain specific details about th
• Haemonetics Corp. Announces Executive and Board Changes — Jan 3, 2025 Risk: low
  Haemonetics Corp. announced on December 27, 2024, a series of executive and board changes. Effective January 3, 2025, Brenda L. Laursen will transition from her
• Haemonetics Corp Files 8-K — Dec 3, 2024 Risk: low
  Haemonetics Corporation filed an 8-K on December 3, 2024, to report other events and financial statements. The filing does not contain specific details about th
• Haemonetics Appoints New CFO, Restructures Key Roles — Sep 16, 2024 Risk: medium
  Haemonetics Corp. announced on September 10, 2024, changes in its executive team. The company appointed Brian J. Smith as Chief Financial Officer and Executive
• Haemonetics to Acquire Sanquin Plasma Services for $100M — Aug 8, 2024 Risk: medium
  Haemonetics Corp. announced on August 8, 2024, that it has entered into a definitive agreement to acquire Sanquin Plasma Services B.V. for approximately $100 mi
• Haemonetics Corp Files 8-K on Shareholder Votes — Jul 25, 2024 Risk: low
  Haemonetics Corporation filed an 8-K on July 25, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain details on
• Haemonetics Corp Files 8-K on Definitive Agreement & Equity Sales — May 29, 2024 Risk: medium
  On May 22, 2024, Haemonetics Corporation entered into a Material Definitive Agreement related to a financial obligation. The company also reported on the unregi
• Haemonetics Corp Files 8-K — May 23, 2024 Risk: low
  On May 22, 2024, Haemonetics Corporation (HAE) filed an 8-K to disclose a Regulation FD event. The filing does not contain specific financial details or materia
• Haemonetics to Acquire Sanquin Plasma Services for $120M — May 21, 2024 Risk: medium
  Haemonetics Corporation announced on May 21, 2024, that it has entered into a definitive agreement to acquire Sanquin Plasma Services BV for approximately $120
• Haemonetics Corp Files 8-K on Operations — May 9, 2024 Risk: low
  Haemonetics Corporation filed an 8-K on May 9, 2024, to report on its results of operations and financial condition. The filing includes financial statements an
• Haemonetics Corp Files 8-K on Agreements — May 1, 2024 Risk: medium
  On April 30, 2024, Haemonetics Corporation entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company also cr
• Haemonetics Corp. Files 8-K Report — Apr 1, 2024 Risk: low
  On April 1, 2024, Haemonetics Corp. filed an 8-K report. The filing indicates that the company is providing information under "Other Events" and "Financial Stat
• Haemonetics to Acquire Sanquin Plasma Services for $100M — Mar 5, 2024 Risk: medium
  Haemonetics Corp. announced on March 5, 2024, that it has entered into a definitive agreement to acquire Sanquin Plasma Services BV, a subsidiary of Sanquin Blo

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX